Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
58.08 M
About GENOCEA BIOSCIENCES INC
Sector
Industry
Headquarters
Cambridge
Website
Founded
2006
FIGI
BBG00XCCRLL8
Genocea Biosciences, Inc. engages in the development and commercialization of cancer immunotherapies. The firm uses its proprietary technology platform, ATLAS, to identify clinically relevant antigens of T cells based on actual human immune responses. Its product candidates include GEN-011, an investigational adoptive T cell therapy and GEN-009, a neoantigen cancer vaccine. The company was founded by Robert Paull and Kevin J. Bitterman on August 16, 2006 and is headquartered in Cambridge, MA.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 0A51 is 0.0000 USD — it hasn't changed in the past 24 hours. Watch GENOCEA BIOSCIENCES INC COM USD0.001(POST REV SPLIT) stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange GENOCEA BIOSCIENCES INC COM USD0.001(POST REV SPLIT) stocks are traded under the ticker 0A51.
0A51 stock hasn't changed in a week, the last month showed zero change in price, over the last year there was no change in GENOCEA BIOSCIENCES INC COM USD0.001(POST REV SPLIT) price.
0A51 reached its all-time high on Feb 16, 2021 with the price of 3.7320 USD, and its all-time low was 0.0000 USD and was reached on Dec 30, 2022. View more price dynamics on 0A51 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
0A51 stock is 0.00% volatile and has beta coefficient of −151.96. Track GENOCEA BIOSCIENCES INC COM USD0.001(POST REV SPLIT) stock price on the chart and check out the list of the most volatile stocks — is GENOCEA BIOSCIENCES INC COM USD0.001(POST REV SPLIT) there?
Yes, you can track GENOCEA BIOSCIENCES INC COM USD0.001(POST REV SPLIT) financials in yearly and quarterly reports right on TradingView.
GENOCEA BIOSCIENCES INC COM USD0.001(POST REV SPLIT) is going to release the next earnings report on Mar 13, 2025. Keep track of upcoming events with our Earnings Calendar.
No, 0A51 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 0A51 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GENOCEA BIOSCIENCES INC COM USD0.001(POST REV SPLIT) stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GENOCEA BIOSCIENCES INC COM USD0.001(POST REV SPLIT) technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GENOCEA BIOSCIENCES INC COM USD0.001(POST REV SPLIT) stock shows the sell signal. See more of GENOCEA BIOSCIENCES INC COM USD0.001(POST REV SPLIT) technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.